Press Releases

In light of the pandemic, the Max Delbrück Center for Molecular Medicine (MDC) is pooling together its resources for projects that advance the understanding of SARS-CoV-2, while scaling down its regular research operations to a minimum. Here’s an overview of the MDC’s current collaborations and plans.

Scientists at the MDC have discovered stem cells responsible for the most common form of kidney cancer. The team of Walter Birchmeier has found a way to block the growth of these tumors in three models of the disease.

Research groups from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) are joining forces with other Berlin-based partners. Pooling their experience and outstanding expertise in the field of mass spectrometry, they will form a new ‘Forschungskern’ or ‘research core’.

Single cell technologies for Personalized Medicine – The Berlin Institute of Health (BIH ), the Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbrück Center for Molecular Medicine (MDC) and Charité – Universitätsmedizin Berlin are launching a joint research initiative.

MDC researchers established a new model to study neuromuscular development and disorders. For the first time two distinct human tissues co-developed in the lab from one progenitor cell type and self-organized into a complex, functional neuromuscular organoid.

The equivalent of almost 28 times around the equator – this was the distance covered by participants in the cycling competition “Wer radelt am meisten?” (Who cycles the most?). Berlin’s senator for sport announced the winners at a ceremony on Wednesday at the Olympiastadion. The Buch campus took first place in the category “Best Company.”

Learning from naked mole-rats is key to Jane Reznick’s research into new therapies for heart disease and strokes. She has now been awarded an ERC Starting Grant, which will help her to start her own group and fund her work to the tune of €1.55 million over five years.

The administrative agreement is signed, the Berlin Institute of Health (BIH ) will become the third pillar of the Charité. "We are excited about the privileged partnership," says Professor Thomas Sommer, interim Scientific Director of the MDC.

Anyone wishing to uncover the mysteries of life must explore the realm of molecules and genes. At the Long Night of the Sciences, visitors to the MDC will voyage through this fascinating cosmos in the company of experts.

More than 450 scientists, clinicians, patients, and stakeholders from 20 European countries have gathered in Berlin at the LifeTime Opening Conference. The pan-European initiative aims to revolutionize healthcare.